2003
DOI: 10.1097/00003226-200305000-00012
|View full text |Cite
|
Sign up to set email alerts
|

Tumor Necrosis Factor Inhibitor Gene Expression Suppresses Lacrimal Gland Immunopathology in a Rabbit Model of Autoimmune Dacryoadenitis

Abstract: In vivo transduction of the lacrimal gland with AdTNFRIp55-Ig resulted in transient expression in the gland and the appearance of TNF-inhibitor protein in tears. The presence of soluble TNF-inhibitor protein partially suppressed the appearance of Sjögren's syndrome-like features of reduced tear production and the immunohistopathology associated with induced autoimmune dacryoadenitis but not tear break-up time and ocular surface disease. This may reflect immunoregulation in the lacrimal gland but not in the con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
28
2
1

Year Published

2004
2004
2009
2009

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 22 publications
2
28
2
1
Order By: Relevance
“…[1][2][3][31][32][33] In this study, we have assessed the consequences of replication-defective and UV-inactivated Ad on secretory compartment organization and function in the acinar epithelial cells of the lacrimal gland. Exposure of lacrimal acini to replicationdefective Ad constructs at an MOI of 5 for 16-18 h Ad modulates epithelial secretory functions Y Wang et al elicited a marked dispersal of rab3D from its normally apical enrichment (Figures 3-5), a change independent of altered rab3D expression (Figure 4) or membrane association ( Figure 6).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[1][2][3][31][32][33] In this study, we have assessed the consequences of replication-defective and UV-inactivated Ad on secretory compartment organization and function in the acinar epithelial cells of the lacrimal gland. Exposure of lacrimal acini to replicationdefective Ad constructs at an MOI of 5 for 16-18 h Ad modulates epithelial secretory functions Y Wang et al elicited a marked dispersal of rab3D from its normally apical enrichment (Figures 3-5), a change independent of altered rab3D expression (Figure 4) or membrane association ( Figure 6).…”
Section: Discussionmentioning
confidence: 99%
“…3 Adenovirus (Ad) vectors, leading candidates for gene therapy to the anterior portion of the eye, do not require cycling of the target cell for gene transfer, and are renowned for mediating gene transfer to nondividing cells, particularly mucosal epithelial cells, with high efficiency. [4][5][6] On the other hand, Ad is intrinsically a lytic virus and is well known to express proteins that effect alterations in a wide variety of cellular processes, including host cell cycle, protein synthesis and survival.…”
Section: Introductionmentioning
confidence: 99%
“…One of the cytokines once considered elementary to inflammation, epithelial attack, and tissue damage in the exocrine tissues in pSS is tumor necrosis factor a (TNFa), and its inhibition was linked to suppression of tissue destruction in lacrimal glands [77,78] and in immortalized human salivary gland acinar cells in vitro [79,80]. In addition, TNFa is capable of inducing apoptosis and reportedly causes redistribution of several autoantigens (such as the nuclear proteins Ro and La and the cytoplasmic protein afodrin) on the cell membrane of apoptotic cells, all consonant with a vital role in pathogenesis.…”
Section: Tnfamentioning
confidence: 99%
“…There has been considerable interest in the application of gene therapy to the anterior segment of the eye for applications including enhancement of corneal and conjunctival wound healing (9), correction of allograft rejection after corneal transplantation (5), and suppression of lacrimal gland autoimmunity associated with Sjögren's syndrome (61,62).…”
mentioning
confidence: 99%
“…Despite real prospects for the rational design of advanced macromolecular therapeutics for treatment of severe dry eye disorders, therapy remains a remote possibility from a drug delivery standpoint. The only methods utilized successfully in animal models for gene delivery to the lacrimal gland have used replication-defective Ad5-derived vectors, which are sufficiently immunogenic to preclude their use in clinical trials (61,62). To our knowledge, there are no reports regarding delivery of other therapeutic molecules such as proteins, peptides, or antisense oligonucleotides into the lacrimal gland.…”
mentioning
confidence: 99%